Mr. Shane Johnson - 02 Nov 2021 Form 3 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
SVP & GM of BayMedica LLC
Signature
/s/ Bruce S. Colwill, by power-of-attorney
Issuer symbol
INM
Transactions as of
02 Nov 2021
Net transactions value
$0
Form type
3
Filing time
09 Nov 2021, 14:50:43 UTC
Next filing
15 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding INM Common Stock 4,574 02 Nov 2021 Direct
holding INM Common Stock 278,428 02 Nov 2021 By Shane A. Johnson TTEE of the Shane A. Johnson Trust DTD April 18, 1997, as amended

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding INM Employee Stock Option (Right to Buy) 02 Nov 2021 Common shares 60,000 $1.40 Direct F1
holding INM Employee Stock Option (Right to Buy) 02 Nov 2021 Common shares 35,000 $1.40 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on 10/18/2021 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant.
F2 Complete vesting shall occur on the one year anniversary of the grant date (October 18, 2022).

Remarks:

Exhibit 24 - Power of Attorney